Name
Session 5: Somatic mutations and disease
Date & Time
Friday, April 25, 2025, 9:30 AM - 12:30 PM
Speakers
Melissa Davis, Morehouse School of Medicine
James Bennett, Seattle Childrens Research Institute
Bob Handsaker, Broad Institute of MIT and Harvard
Martin Blohmer, Harvard Medical School
Maria Torra I Benach, Wellcome Sanger Institute
Sarah Aitken, Yale University
Henry Lee-Six, Wellcome Sanger Institute
Jennifer Ziegenfuss, University of Massachusetts Chan Medical School
James Bennett, Seattle Childrens Research Institute
Bob Handsaker, Broad Institute of MIT and Harvard
Martin Blohmer, Harvard Medical School
Maria Torra I Benach, Wellcome Sanger Institute
Sarah Aitken, Yale University
Henry Lee-Six, Wellcome Sanger Institute
Jennifer Ziegenfuss, University of Massachusetts Chan Medical School



Description
While most somatic mutations are functionally neutral, some can profoundly alter a cell’s phenotype and are associated with disease. Cancer is the best-known example, but other diseases including chronic liver disease, Huntington’s disease, and neurodevelopmental disorders are caused by somatic mutation or influence the selection of somatic clones. In this session, we will focus on how somatic mutations and evolution can lead to dysfunction, disease and treatment resistance, and why different populations are at different risk of somatic mutation-related diseases, and the challenges in diagnosing mosaic or tissue-specific disease.